Search

Your search keyword '"Hung CS"' showing total 377 results

Search Constraints

Start Over You searched for: Author "Hung CS" Remove constraint Author: "Hung CS"
377 results on '"Hung CS"'

Search Results

301. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.

302. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

303. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.

304. Contribution of autolysin and Sortase a during Enterococcus faecalis DNA-dependent biofilm development.

305. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO.

306. Emerging concepts of biofilms in infectious diseases.

307. Cytotoxic triterpenoids from the stems of Microtropis japonica.

308. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks.

309. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects.

310. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A.

311. Suppression of hepatitis B viral gene expression by phosphoinositide 5-phosphatase SKIP.

312. A high speed detection platform based on surface-enhanced Raman scattering for monitoring antibiotic-induced chemical changes in bacteria cell wall.

313. A murine model of urinary tract infection.

314. Using paper chart based clinical reminders to improve guideline adherence to lipid management.

315. Streptozocin-induced diabetic mouse model of urinary tract infection.

317. Time-dependent benefit of initial thrombosuction on myocardial reperfusion in primary percutaneous coronary intervention.

318. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians.

319. A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.

320. Biogeochemical responses to the removal of maricultural structures from an eutrophic lagoon (Tapong Bay) in Taiwan.

321. High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis.

322. Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3.

323. Isolated Langerhans cell histiocytosis of the thyroid in a female infant.

324. Usefulness of drug eluting stent in percutaneous coronary intervention--a single center experience in Taiwan.

325. Effects of lactose and glucose on production of itaconic acid and lovastatin by Aspergillus terreus ATCC 20542.

326. Mobile phone 'talk-mode' signal delays EEG-determined sleep onset.

327. Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.

328. The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine.

329. Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation.

330. Coexistence of megaloblastic anemia and iron deficiency anemia in a young woman with chronic lymphocytic thyroiditis.

331. The impact of lesion length on angiographic restenosis after vertebral artery origin stenting.

332. The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation.

333. Outcome of primary percutaneous coronary intervention in octogenarians with acute myocardial infarction.

334. Primitive neuroectodermal tumor of the brain in a girl with Turner syndrome diagnosed after 4 years of growth hormone therapy.

335. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach.

336. Clinical and laboratory findings at initial diagnosis in pediatric Graves' disease in Taiwan.

337. Clinical application of Carlsson's questionnaire to predict erosive GERD among healthy Chinese.

338. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.

339. Morphological and biochemical changes of andrographolide-induced cell death in human prostatic adenocarcinoma PC-3 cells.

340. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.

341. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.

342. Human epidermal growth factor enhances healing of diabetic foot ulcers.

343. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli.

344. Replication of hepatitis B in HBsAg-positive siblings.

345. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.

346. MR perfusion studies of brain for patients with unilateral carotid stenosis or occlusion: evaluation of maps of "time to peak" and "percentage of baseline at peak".

347. Review of pre-eclampsia in Taiwan: a multi-institutional study.

348. Relationship between productive HIV-1 infection of macrophages and CCR5 utilization.

349. Replication of hepatitis B virus in first-degree relatives of patients with hepatocellular carcinoma.

350. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.

Catalog

Books, media, physical & digital resources